vs
Side-by-side financial comparison of ADMA BIOLOGICS, INC. (ADMA) and Core Scientific, Inc. (CORZ). Click either name above to swap in a different company.
ADMA BIOLOGICS, INC. is the larger business by last-quarter revenue ($139.2M vs $79.8M, roughly 1.7× Core Scientific, Inc.). Core Scientific, Inc. runs the higher net margin — 268.5% vs 35.5%, a 233.0% gap on every dollar of revenue. On growth, ADMA BIOLOGICS, INC. posted the faster year-over-year revenue change (18.4% vs -16.0%). ADMA BIOLOGICS, INC. produced more free cash flow last quarter ($34.6M vs $-450.8M). Over the past eight quarters, ADMA BIOLOGICS, INC.'s revenue compounded faster (30.4% CAGR vs -33.3%).
ADMA Biologics Inc. is a biopharmaceutical enterprise focused on the research, development, manufacturing and commercialization of specialty plasma-derived immunoglobulin therapies. It primarily operates in the United States, catering to patients with primary immunodeficiency and other immune-related disorders, healthcare providers and medical institutions across its core immune health therapeutic segment.
Core Scientific is a leading digital asset and high-performance computing infrastructure provider. It operates large energy-efficient data centers across North America, offering cryptocurrency mining services, colocation hosting for blockchain and AI clients, and custom high-performance computing solutions for enterprise tech segments.
ADMA vs CORZ — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $139.2M | $79.8M |
| Net Profit | $49.4M | $214.2M |
| Gross Margin | 63.8% | 26.0% |
| Operating Margin | 45.1% | -149.5% |
| Net Margin | 35.5% | 268.5% |
| Revenue YoY | 18.4% | -16.0% |
| Net Profit YoY | -55.9% | 180.6% |
| EPS (diluted) | $0.20 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $139.2M | $79.8M | ||
| Q3 25 | $134.2M | $81.1M | ||
| Q2 25 | $122.0M | $78.6M | ||
| Q1 25 | $114.8M | $79.5M | ||
| Q4 24 | $117.5M | $94.9M | ||
| Q3 24 | $119.8M | $95.4M | ||
| Q2 24 | $107.2M | $141.1M | ||
| Q1 24 | $81.9M | $179.3M |
| Q4 25 | $49.4M | $214.2M | ||
| Q3 25 | $36.4M | $-144.0M | ||
| Q2 25 | $34.2M | $-936.8M | ||
| Q1 25 | $26.9M | $576.3M | ||
| Q4 24 | $111.9M | $-265.5M | ||
| Q3 24 | $35.9M | $-455.3M | ||
| Q2 24 | $32.1M | $-902.2M | ||
| Q1 24 | $17.8M | $210.7M |
| Q4 25 | 63.8% | 26.0% | ||
| Q3 25 | 56.3% | 4.8% | ||
| Q2 25 | 55.1% | 6.4% | ||
| Q1 25 | 53.2% | 10.3% | ||
| Q4 24 | 53.9% | 5.0% | ||
| Q3 24 | 49.8% | -0.2% | ||
| Q2 24 | 53.6% | 27.5% | ||
| Q1 24 | 47.8% | 43.3% |
| Q4 25 | 45.1% | -149.5% | ||
| Q3 25 | 38.0% | -67.6% | ||
| Q2 25 | 35.1% | -33.4% | ||
| Q1 25 | 30.4% | -59.1% | ||
| Q4 24 | 32.6% | -41.9% | ||
| Q3 24 | 33.1% | -43.2% | ||
| Q2 24 | 36.6% | -64.3% | ||
| Q1 24 | 26.7% | 30.8% |
| Q4 25 | 35.5% | 268.5% | ||
| Q3 25 | 27.1% | -177.6% | ||
| Q2 25 | 28.1% | -1191.4% | ||
| Q1 25 | 23.4% | 724.6% | ||
| Q4 24 | 95.2% | -279.7% | ||
| Q3 24 | 30.0% | -477.4% | ||
| Q2 24 | 29.9% | -639.4% | ||
| Q1 24 | 21.7% | 117.5% |
| Q4 25 | $0.20 | $-1.63 | ||
| Q3 25 | $0.15 | $-0.45 | ||
| Q2 25 | $0.14 | $-0.04 | ||
| Q1 25 | $0.11 | $1.24 | ||
| Q4 24 | $0.45 | $0.51 | ||
| Q3 24 | $0.15 | $-1.17 | ||
| Q2 24 | $0.13 | $-5.05 | ||
| Q1 24 | $0.08 | $0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $87.6M | $311.4M |
| Total DebtLower is stronger | $72.1M | — |
| Stockholders' EquityBook value | $477.3M | $-962.7M |
| Total Assets | $624.2M | $2.3B |
| Debt / EquityLower = less leverage | 0.15× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $87.6M | $311.4M | ||
| Q3 25 | $61.4M | $453.4M | ||
| Q2 25 | $90.3M | $581.3M | ||
| Q1 25 | $71.6M | $697.9M | ||
| Q4 24 | $103.1M | $836.2M | ||
| Q3 24 | $86.7M | $253.0M | ||
| Q2 24 | $88.2M | $96.1M | ||
| Q1 24 | $45.3M | $98.1M |
| Q4 25 | $72.1M | — | ||
| Q3 25 | $72.4M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $72.3M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $477.3M | $-962.7M | ||
| Q3 25 | $431.2M | $-1.3B | ||
| Q2 25 | $398.3M | $-1.2B | ||
| Q1 25 | $373.4M | $-308.8M | ||
| Q4 24 | $349.0M | $-943.0M | ||
| Q3 24 | $231.9M | $-826.7M | ||
| Q2 24 | $188.3M | $-1.2B | ||
| Q1 24 | $153.7M | $-318.5M |
| Q4 25 | $624.2M | $2.3B | ||
| Q3 25 | $568.7M | $2.2B | ||
| Q2 25 | $558.4M | $1.9B | ||
| Q1 25 | $510.6M | $1.5B | ||
| Q4 24 | $488.7M | $1.5B | ||
| Q3 24 | $390.6M | $824.6M | ||
| Q2 24 | $376.4M | $664.2M | ||
| Q1 24 | $350.9M | $814.0M |
| Q4 25 | 0.15× | — | ||
| Q3 25 | 0.17× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $35.6M | $278.3M |
| Free Cash FlowOCF − Capex | $34.6M | $-450.8M |
| FCF MarginFCF / Revenue | 24.8% | -565.1% |
| Capex IntensityCapex / Revenue | 0.8% | 914.0% |
| Cash ConversionOCF / Net Profit | 0.72× | 1.30× |
| TTM Free Cash FlowTrailing 4 quarters | $27.8M | $-779.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $35.6M | $278.3M | ||
| Q3 25 | $13.3M | $131.8M | ||
| Q2 25 | $21.1M | $34.0M | ||
| Q1 25 | $-19.7M | $-45.0M | ||
| Q4 24 | $50.2M | $42.9M | ||
| Q3 24 | $25.0M | $5.7M | ||
| Q2 24 | $45.6M | $1.2M | ||
| Q1 24 | $-2.2M | $22.2M |
| Q4 25 | $34.6M | $-450.8M | ||
| Q3 25 | $-1.1M | $-112.7M | ||
| Q2 25 | $18.7M | $-87.3M | ||
| Q1 25 | $-24.4M | $-129.0M | ||
| Q4 24 | $47.5M | $-52.1M | ||
| Q3 24 | $24.0M | $-25.5M | ||
| Q2 24 | $43.6M | $-1.9M | ||
| Q1 24 | $-4.6M | $-9.7M |
| Q4 25 | 24.8% | -565.1% | ||
| Q3 25 | -0.8% | -139.0% | ||
| Q2 25 | 15.3% | -111.0% | ||
| Q1 25 | -21.2% | -162.2% | ||
| Q4 24 | 40.4% | -54.8% | ||
| Q3 24 | 20.0% | -26.7% | ||
| Q2 24 | 40.7% | -1.4% | ||
| Q1 24 | -5.6% | -5.4% |
| Q4 25 | 0.8% | 914.0% | ||
| Q3 25 | 10.7% | 301.5% | ||
| Q2 25 | 2.0% | 154.2% | ||
| Q1 25 | 4.1% | 105.6% | ||
| Q4 24 | 2.3% | 100.0% | ||
| Q3 24 | 0.9% | 32.7% | ||
| Q2 24 | 1.9% | 2.2% | ||
| Q1 24 | 2.9% | 17.8% |
| Q4 25 | 0.72× | 1.30× | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.62× | — | ||
| Q1 25 | -0.73× | -0.08× | ||
| Q4 24 | 0.45× | — | ||
| Q3 24 | 0.70× | — | ||
| Q2 24 | 1.42× | — | ||
| Q1 24 | -0.12× | 0.11× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ADMA
| ADMA Bio Manufacturing Segment | $123.1M | 88% |
| Other | $16.0M | 12% |
CORZ
| Other | $36.3M | 46% |
| Digital Asset Self Mining Service | $31.8M | 40% |
| Colocation Service | $11.6M | 15% |
